BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10229820)

  • 1. Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells.
    Byrd VM; Ballard DW; Miller GG; Thomas JW
    J Immunol; 1999 May; 162(10):5853-9. PubMed ID: 10229820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
    Kalli K; Huntoon C; Bell M; McKean DJ
    Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
    Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
    Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation.
    Aune TM; Mora AL; Kim S; Boothby M; Lichtman AH
    J Immunol; 1999 May; 162(10):5805-12. PubMed ID: 10229814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel.
    Martin AG; Fresno M
    J Biol Chem; 2000 Aug; 275(32):24383-91. PubMed ID: 10823840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28.
    Herndon TM; Shan XC; Tsokos GC; Wange RL
    J Immunol; 2001 May; 166(9):5654-64. PubMed ID: 11313406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
    Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
    Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.
    Bash J; Zong WX; Banga S; Rivera A; Ballard DW; Ron Y; Gélinas C
    EMBO J; 1999 May; 18(10):2803-11. PubMed ID: 10329626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin.
    Lai JH; Tan TH
    J Biol Chem; 1994 Dec; 269(48):30077-80. PubMed ID: 7982907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
    Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
    Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.
    Bryan RG; Li Y; Lai JH; Van M; Rice NR; Rich RR; Tan TH
    Mol Cell Biol; 1994 Dec; 14(12):7933-42. PubMed ID: 7969133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
    Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
    J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers.
    Harhaj EW; Maggirwar SB; Good L; Sun SC
    Mol Cell Biol; 1996 Dec; 16(12):6736-43. PubMed ID: 8943328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.
    Su F; Schneider RJ
    J Virol; 1996 Jul; 70(7):4558-66. PubMed ID: 8676482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell.
    Ho LJ; Juan TY; Chao P; Wu WL; Chang DM; Chang SY; Lai JH
    Br J Pharmacol; 2004 Dec; 143(7):919-27. PubMed ID: 15504755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.